biriperone

This page covers all biriperone drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting D(3) dopamine receptor, 5-hydroxytryptamine receptor 2A, D(1A) dopamine receptor.

Targets

D(3) dopamine receptor, 5-hydroxytryptamine receptor 2A, D(1A) dopamine receptor

Phase 2 pipeline (1)

• Centbutindole · Other
  Centbutindole works by binding to the D(3) dopamine receptor, which is involved in regulating movement and other functions in the brain.

Patent intelligence

• biriperone patent landscape — aggregated cliff calendar, attackable patents, originator estates